MURA 7012
Alternative Names: MURA-7012Latest Information Update: 13 Mar 2025
At a glance
- Originator Mural Oncology
- Class Antineoplastics; Immunoglobulin fragments; Immunotherapies; Interleukins
- Mechanism of Action Interleukin 12 inhibitors; Interleukin replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer